货号:A467450
同义名:
CTEP Derivative; Rg7090
RG7090 is a potent, selective and orally available mGlu5 negative allosteric modulator with a Kd of 1.1 nM.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Basimglurant (RG7090) is a potent, selective and orally available mGlu5 negative allosteric modulator with a Kd of 1.1 nM[1]. |
Animal study | Basimglurant (RG7090) is a potent, selective, and safe mGlu5 inhibitor with good oral bioavailability and long half-life supportive of once-daily administration, good brain penetration, and high in vivo potency. Its ability to alleviate symptoms of depression is validated through functional magnetic resonance imaging (fMRI) assessments, alongside its capacity to produce anxiolytic-like and antinociceptive effects[1].Basimglurant is undergoing phase II clinical trials for depression and fragile X syndrome treatment, Basimglurant consistently extends drinking time in the Vogel conflict drinking test in a dose-dependent manner. Effective doses of Basimglurant (RG7090) yield a plasma exposure range from 5 ng/mL (0.03 mg/kg) to 37 ng/mL (0.3 mg/kg)[2]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.07mL 0.61mL 0.31mL |
15.35mL 3.07mL 1.53mL |
30.70mL 6.14mL 3.07mL |
CAS号 | 802906-73-6 |
分子式 | C18H13ClFN3 |
分子量 | 325.77 |
SMILES Code | CC1=C(C#CC2=CC(Cl)=NC=C2)N=C(C)N1C3=CC=C(F)C=C3 |
MDL No. | MFCD25976719 |
别名 | CTEP Derivative; Rg7090 |
运输 | 蓝冰 |
InChI Key | UPZWINBEAHDTLA-UHFFFAOYSA-N |
Pubchem ID | 11438771 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|